Prevention is more effective than treatment
Clinical trials have shown that Semaglutide can help patients lose up to 15% of their body weight, while Tirzepatide has demonstrated weight loss of over 20% in some cases
Clinical trials show semaglutide reduces systolic blood pressure by around 3.5-5 mmHg compared to placebo, likely due to weight loss and direct metabolic effects
Semaglutide, GLP-1 Drugs, and IBS: Managing Side Effects and Gut Health Aleks Jagiello BSc, MSc, RD Sep 11, 2025 17 min read Glucagon-like peptide-1 (GLP-1) receptor agonist medications, such as semaglutide (brand names Wegovy, Ozempic ), have surged in popularity for weight loss and type 2 diabetes management
Introduction to Semaglutide Semaglutide is a glucagonlike peptide1 (GLP1) receptor agonist that has transformed chronic weight management